Table 3.
Method/Dimension | Reference/Year | Liver | Lesion |
---|---|---|---|
residual UNet/2.5D | [18]/2017 | - | 67% |
UNet + graph cut/2D | [13]/2019 | 95.05% | - |
TDP-CNN/3D | [14]/2020 | 96.50% | 68.9% |
3D RA-UNet/3D | [16]/2020 | 96.10% | - |
SAR-UNet/2D | [15]/2021 | 95.71% | 59.5% |
2.5D UNet/similar3D | [19]/2021 | 95.30% | 78.4 ± 16% |
XNet/3D | [20]/2021 | 97.10% | 84.3% |
3D U-Net/3D | [34]/2022 | 94.20% | |
CEDRNN/2D | [35]/2022 | 95.20% | - |
EfficientNet and Attention-Based Residual U-Net/2D |
[36]/2022 | 95.20% | - |
Decision fusion/2D | our | 95.76% | 75.83% |